Anest. intenziv. Med. 2015;26(4):236-238

Rabdomyolýza - kdy na ni myslet?Postgraduate education - Selected Topics in Clinical Physiology

V. Černý

Published: August 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Černý V. Rabdomyolýza - kdy na ni myslet? Anest. intenziv. Med. 2015;26(4):236-238.
Download citation

References

  1. Mirrakhimov AE, Voore P, Halytskyy O, Khan M, Ali AM. Propofol infusion syndrome in adults: a clinical update. Crit Care Res Pract. 2015;2015:260385. Go to original source... Go to PubMed...
  2. Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhab-domyolysis: pathogenesis, diagnosis, and treatment. Ochsner J. 2015 Spring;15(1):58-69. Review.
  3. Ayach T, Nappo RW, Paugh-Miller JL, Ross EA. Postoperative hyperkalemia. Eur J Intern Med. 2015 Mar;26(2):106-111. Go to original source... Go to PubMed...
  4. Magni P, Macchi C, Morlotti B, Sirtori CR, Ruscica M. Risk identification and possible countermeasures for muscle adverse effects during statin therapy. Eur J Intern Med. 2015 Mar;26(2):82-88. Go to original source... Go to PubMed...
  5. Chan EK, Kornberg AJ, Ryan MM. A diagnostic approach to recurrent myalgia and rhabdomyolysis in children. Arch Dis Child. 2015 Jan 29; pii: archdischild-2014-307663. Go to original source... Go to PubMed...
  6. Feng Q. Approach to clinical and genetic characterization of statin-induced myopathy. Methods Mol Biol. 2014;1175:67-90. Go to original source... Go to PubMed...
  7. Sharp LJ, Haller RG. Metabolic and mitochondrial myopathies. Neurol Clin. 2014 Aug;32(3):777-799, ix. Go to original source... Go to PubMed...
  8. Pasnoor M, Barohn RJ, Dimachkie MM. Toxic myopathies. Neurol Clin. 2014 Aug;32(3):647-670, viii. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.